Cancer clinical trials in the United States appear to be rebounding after a significant slowdown during the pandemic, researchers say. For the study, the investigators analyzed data from the Dana-Farber Cancer Institute in Boston and the Tisch Cancer Institute at Mount Sinai Medical School in New York City on more than 4,700 new patients enrolled… read on > read on >
Overall use of insulin pumps among U.S. youngsters with type 1 diabetes has climbed in recent decades, but those who are poor or from minority groups are less likely to have the devices, a new study finds. Insulin pumps, which do away with the need for numerous painful injections, have been shown to improve control… read on > read on >
Many people think they make healthy food choices, but they may be viewing their diet through rose-colored glasses. That’s the main finding of a new study that aimed to identify disconnects between how healthfully Americans think they eat and how they actually do. “It appears difficult for adults in the United States to accurately assess… read on > read on >
The expression “plays well with others” is often tossed around to describe people who are less likely to ruffle feathers, and new research shows these sandbox skills really matter. It turns out that kids who play well with others in preschool are less likely to experience mental health issues as they grow up. The findings… read on > read on >
TUESDAY, June 14, 2022 (American Heart Association News) — LGBTQ people may celebrate as one during Pride Month. But when the topic is health, experts say it’s crucial to acknowledge differences. Too often, LGBTQ people are considered one entity, “as if they all have the same issues, all have the same needs,” said Dr. Carl… read on > read on >
The first pill to treat adults with severe alopecia was approved by the U.S. Food and Drug Administration on Monday. Olumiant (baricitinib) is the first FDA-approved alopecia therapy that treats the entire body rather than a specific spot, the agency said in a news release announcing the approval. “Access to safe and effective treatment options… read on > read on >
Despite worries that COVID-19 symptoms can return after patients take the drug Paxlovid, such cases of rebound symptoms are actually rare, a new study shows. In an advisory last month, the U.S. Centers for Disease Control and Prevention cautioned that COVID-19 can sometimes make a comeback after an infected person has gone through a round… read on > read on >
Bouncing on a trampoline is always risky, but kids are more likely to suffer serious injuries at a trampoline center than at home, according to researchers who are calling for mandatory safety standards at the centers. U.S. emergency departments treat nearly 100,000 children a year for trampoline injuries. The popularity of trampoline centers has soared… read on > read on >
In yet another sign that the pandemic has exacerbated disparities in health care, researchers report that the life expectancy of Native Americans plummeted by nearly five years as the new coronavirus raged across the country. The loss in longevity was far greater than any other ethnic group and about three times higher than whites. The… read on > read on >
Called “forever chemicals” because they linger in the environment, new research suggests that middle-aged women with high levels of perfluoroalkyls and polyfluoroalkyls (PFAS) in their blood may be more vulnerable to high blood pressure. In the study, women aged 45 to 56 who had the highest concentrations of seven of these chemicals were 71% more… read on > read on >
